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One appraisal of the efficacy of percutaneous cholecystostomy
The indications for percutaneous cholecystostomy (PC) include Grade II acute cholecystitis (AC) with
severe inflammation, Grade III AC with organ dysfunction, or AC in patients with severe co-morbidity
limiting surgical options. Today’s published studies support its efficacy. The technical success rate of
radiologically-guided PC exceeds 90% in most studies and procedure related complications are infre-
quent, especially for a transhepatic route.Once the inflammatory AC has resolved, cholecystectomy (CCx,
usually laparoscopic) can be performed early (within 1-7 days) or delayed (6-8 weeks) with excellent
success, and low conversion rates. Some advocate using PC as definitive treatment for AC in high-risk and
elderly patients. Once resolved, the catheter is safely removed. Without subsequent CCx, biliary symp-
toms will recur in 10-35% of cases. Sanjay et al. offer a retrospective review of 53 PC patients derived over
nearly 11 years at two university hospitals. With such low numbers of cases, questions arise as to how
representative this multicentre analysis really is. While the authors’ indications for PC were sound, their
results both aligned with (recurrent AC) and departed from (PC complications, need for open CCx)
contemporary available evidence. Further, there are no comparisons made to other patients with similar
indications treated with index CCx or medically. Combined with its cited references, this report does
however provide readers with a practical framework to audit their own PC results.
Mark Callery
Should the biliary tree be routinely decompressed following
liver resection?
Bile leak following hepatic resection is a technical complication associated with increased morbidity. It is of
such importance that it has recently been defined to allowing standardized reporting. In this issue of HPB,
Nanashima et al. describe a retrospective series of 550 patients who underwent hepatic resection over 2
decades.During this time period, the concept of decompressing the biliary tree externally by a tube (C-tube)
placed via the cystic duct into the main bile duct was introduced. The use of such a tube was left to the
discretion of the surgeon.All hepatic resections had peritoneal drains placed routinely. The incidence of bile
leak post hepatectomywas 8%.Of these 44patients,31 and5had ISGLSGradeB andCbile leaks respectively.
Onmultivariate analysis,post operative bile leakagewas associatedwith the transection technique and longer
operating time but not C tube usage.However, in those patients who had amajor hepatic resection there was
a reduction in severity of the ISGLS grade of bile leak in thosewhohad aC tubeplaced.Decompressionof the
biliary tree seems a logical step in reducing the incidence of bile leak so why did it not prevent it? One
possibility is that some bile leaks were due to small volume segmental disconnection of the biliary tree from
themainbiliary systemandsubsequently resolvedspontaneously.Could theCtubehavehadhigher resistance
to flow than the biliary leak via peritoneal drains?Other factors including caliber of the peritoneal drains,use
of suction and position of drainage bags in relation to patient position were not described in detail thus
limiting any conclusions. So should C-tubes be used routinely? From the data provided, it cannot be
recommended for routine use but in complicated high risk patients it may be worth considering in an effort
to reduce the severity of any subsequent biliary leak.Whether this is better thanmeticulous exclusion of bile
leaks at operation, an internal stent or on demand endoscopic stenting is yet to be determined.
Saxon Connor
Singing the obesity blues in liver transplantation for
hepatocellular carcinoma
Obesity is a global problem and fatty liver disease is one of many consequences of the changing waistlines
of society. The association between obesity and development of non-alcoholic fatty liver disease and
cirrhosis, in its own right or as a cofactor for other diseases, has been long known. Similarly the
association with hepatocellular carcinoma (HCC) is well documented. In this edition of HPB, Mathur
and colleagues from Florida explore the outcomes of their patients undergoing liver transplantation for
HCC in relation to obesity. They found higher postoperative complication rates and length of stay in
overweight patients in keeping with other studies. The novel finding of this study was the association
between obesity and the higher incidence of recurrence of HCC, which also occurred more rapidly,
compared with non-obese patients. The authors argue that obesity may be an adverse factor for outcome
in liver transplantation for HCC and the doubling of the hazard ratio which they observed would support
this.Whether this information will alter the listing behaviours of centres remains to be seen but I suspect
a larger cohort will need to be studied to provide corroboration. This paper, along with other studies
indicating high rates of cardiovascular events after liver transplantation in obese patients, also raises the
question of whether there is a role for bariatric surgery or other weight loss measures to try and improve
outcomes of this group after the major resource investment that is liver transplantation.
Stephen J Wigmore
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